A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2004
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552414A Chinese medicine composition and preparing method thereof
12/08/2004	CN1552411A External used Chinese medicine for treating spondylopathy
12/08/2004	CN1552373A Pills for preventing osteoproliferation and preparing method thereof
12/08/2004	CN1552362A Muscle relaxing pills and their preparation
12/08/2004	CN1552360A Gusongbao pills against osteoporosis and their preparation
12/08/2004	CN1552357A Chuanlong spur pills and their preparation
12/08/2004	CN1552355A Rue extract preparing method
12/08/2004	CN1552345A Medicine for preventing arthritis
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178931C Substituted pyrazole compounds
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178915C Alkynyl containing hydroxamic acid derivatives and its preparation and its use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178889C Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/02/2004	WO2004104188A1 Method for the in vitro production of cartilage-like tissue
12/02/2004	WO2004104159A1 Method and apparatus for mechanical stimulation of tissue in vitro
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103980A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103380A1 Water-soluble isoflavone composition, process for producing the same, and use thereof
12/02/2004	WO2004103377A1 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
12/02/2004	WO2004103365A1 Antiarthritic combinations
12/02/2004	WO2004083364A3 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2004020584A3 Antagonists of chemokine receptors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	US20040243316 Crystallographic structure of the androgen receptor ligand binding domain
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242853 Glp-1 exendin-4 peptide analogs and uses thereof
12/02/2004	US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis
12/02/2004	US20040242498 CXCR3 antagonists
12/02/2004	US20040242491 For use in the treatment of gout and related symptoms or in the amelioration of symptoms related to a high level of uric acid such as muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, or as a dietary supplement
12/02/2004	US20040242478 5-cnac as oral delivery agent for parathyroid hormone fragments
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040241815 Process for producing 1,4-dihysdroxy-2-naphthoic acid
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids
12/02/2004	US20040241145 adhesion of mesenchymal stem cells or osteoblasts to fibers and/or porometric material which can serve as biological scaffold for the cells; tissue engineering
12/02/2004	US20040241144 mixing of synovial fluid and mesenchymal cells for use in tissue engineering; prophylaxis of degenerative joint diseases
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2525945A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	CA2524116A1 Antiarthritic combinations
12/02/2004	CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481977A1 Nitrogen-containing heterocyclic compound
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481251A2 Estrogen receptor interaction with a transcription factor
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1481065A2 Method for detection of leptin receptor ligands
12/01/2004	EP1481010A2 Anti-interleukin-1 beta analogs
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof
12/01/2004	EP1480976A1 Thiazole derivatives as npy receptor antagonists
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480971A1 Isoquinoline derivatives
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480687A1 Modified phosphocalcic compound, injectable composition containing same
12/01/2004	EP1480674A1 Treatment of central nervous system damage
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480639A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
12/01/2004	EP1480637A1 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
12/01/2004	EP1480627A1 Methods of reducing angiogenesis
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1379139A4 The use of ecm degrading enzymes for the improvement of cell transplantation
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1175408B1 Pyrimidinone compounds
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP1119611A4 Method for the treatment of chemonucleolysis
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules

1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 820